Avenira Limited (AEV) AI Stock Analysis

Avenira Limited has lodged its annual corporate governance statement for the year ended 30 June 2026, confirming board approval and hosting the document on its governance webpage. The filing is accompanied by a completed Appendix 4G, which acts as a...

Avenira Limited is an Australian-listed company whose latest communication is its annual report for the 2026 financial year. The report package reflects standard corporate disclosure practices, including audited financial statements, governance comme...

Avenira Limited has lodged an updated Appendix 3B with the ASX for a proposed renounceable pro rata issue of securities. The update relates to an existing capital-raising proposal that is being conducted under ASX listing rules and is intended to be...

Avenira Limited has updated shareholders on its pro rata renounceable rights issue, which offers three new shares for every two held and aims to raise up to about $48.9 million before costs. Major shareholder Hebang Biotechnology has committed to tak...

Avenira has signed a four-year offtake and distribution agreement with Hebang Biotechnology for 500,000 tonnes per annum of phosphate rock from its Wonarah project, securing a sales pathway for more than 80% of the expected annual DSO production. Und...

Avenira Limited has commenced an 11,590-metre air core drilling campaign at its Jundee South Gold Project in Western Australia, signalling a significant push to advance exploration in the area. The program targets multiple tenements using geological...

Avenira Limited has updated its proposed renounceable pro rata issue of securities, lodged via an Appendix 3B filing with the ASX. The update confirms that the offer remains a rights-style capital raising directed at existing shareholders, with the s...

Avenira Limited has updated its proposed renounceable pro rata issue of securities, lodging an amended Appendix 3B with the ASX on 7 September 2026. The key change is an extension of the offer’s closing date from the schedule outlined in its pr...

Avenira Limited has launched a three-for-two renounceable rights issue to raise up to $49 million, with a prospectus lodged with ASIC in mid-August 2026. The capital raising is intended to fund the transition of its Wonarah project from a permitted s...

Avenira Limited has launched a pro-rata renounceable rights issue, offering eligible shareholders three new shares for every two held at an issue price of $0.006, to raise up to about $48.9 million before costs. The offer is tradeable on ASX and incl...

Avenira Limited has opened a pro-rata renounceable rights issue, offering eligible shareholders three new shares for every two held at an issue price of $0.006 per share, to raise up to about $48.9 million before costs. The prospectus has been dispat...

Avenira Limited has commenced trading of rights under its renounceable entitlement issue on the ASX, listed as AEVR, following the announcement earlier in the week. Rights trading is scheduled to run until 3 September 2026, giving investors a defined...

Avenira Limited has launched a renounceable pro-rata entitlement offer to raise up to approximately $48.9 million before costs, issuing up to 8.15 billion new shares at $0.006 each on the basis of three new shares for every two held. Eligible shareho...

Avenira Limited has launched a three-for-two renounceable rights issue priced at 0.6 cents per share to raise up to approximately $49 million, a discount to its recent trading levels, with rights trading commencing on 19 August 2026 and the offer clo...

Avenira Limited has resolved to change its financial year-end from 30 June to 31 December to align with the financial calendar of its major shareholder, Sichuan Hebang Biotechnology Corporation. The board says the move, made under Australian corporat...

Avenira’s June quarter activities show the Wonarah Phosphate Project advancing with key team appointments, infrastructure tenders, and heritage processes underway, alongside strengthened funding after a Hebang placement and repayment of a previ...

Avenira Limited has advised that it has issued 1,171,445,635 fully paid ordinary shares, which have been quoted on the ASX without a prospectus under the disclosure exemptions of the Corporations Act. The company confirmed it is up to date with its f...